CORNELL UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1865-04-27
- Employees
- 10K
- Market Cap
- -
Clinical Trials
94
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (70 trials with phase data)• Click on a phase to view related trials
Income Volatility and Mental Health, Full Experiment
- Conditions
- DepressionAnxietyBlood Pressure
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Cornell University
- Target Recruit Count
- 2267
- Registration Number
- NCT06988410
- Locations
- 🇬🇭
Innovations for Poverty Action, Tamale, Ghana
The Locus Coeruleus, Norepinephrine and Cognitive Aging
- Conditions
- Alzheimer Disease
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Cornell University
- Target Recruit Count
- 150
- Registration Number
- NCT06880510
- Locations
- 🇺🇸
Cornell University, Ithaca, New York, United States
The Precision Nutrition New York Study
- Conditions
- Body Composition ChangesBody Weight Changes
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Cornell University
- Target Recruit Count
- 15
- Registration Number
- NCT06777498
- Locations
- 🇺🇸
Cornell University, Ithaca, New York, United States
Advanced Cooking Education Full Scale Study
- Conditions
- Nutrition, HealthyAdolescent Behavior
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Cornell University
- Target Recruit Count
- 200
- Registration Number
- NCT06558396
- Locations
- 🇺🇸
Cornell University, Ithaca, New York, United States
In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2Diabetes MellitusChildhood ObesityPediatric ObesityGlucose Metabolism DisordersOvernutritionOverweightBody WeightBehavior, AdolescentMetabolic Disease
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Cornell University
- Target Recruit Count
- 60
- Registration Number
- NCT06557317
- Locations
- 🇺🇸
Brownsville Neighborhood Health Action Center, Brooklyn, New York, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 18
- Next
News
Cornell Develops 'Stealthy' Lipid Nanoparticles to Enhance mRNA Vaccine Delivery and Reduce Immune Side Effects
Cornell researchers have developed a new material that could significantly improve mRNA vaccine delivery and effectiveness by replacing ingredients that may trigger unwanted immune responses.
Biostate AI Secures $12M Series A to Revolutionize RNA Sequencing and Molecular Diagnostics
Biostate AI has raised $12 million in Series A funding led by Accel to develop affordable RNA sequencing technology and AI-powered diagnostic models.
Biostate AI and Weill Cornell Medicine Partner to Develop AI-Driven Personalized Treatment Models for Leukemia
Biostate AI and Weill Cornell Medicine have formed a strategic collaboration to develop AI models for personalized leukemia care, initially focusing on acute myeloid leukemia (AML) using RNA sequencing technology.
AVMA and Cornell University Launch Clinical Trial to Combat Veterinary Burnout
The AVMA and Cornell University are collaborating on a clinical trial to address burnout among veterinary professionals, funded by AVMA and Zoetis.